Nuclear Medicine and Radiopharmaceutic Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Nuclear Medicine and Radiopharmaceutic market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.3% during the forecast period.

    This report presents the market size and development trends by detailing the Nuclear Medicine and Radiopharmaceutic market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Nuclear Medicine and Radiopharmaceutic market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Nuclear Medicine and Radiopharmaceutic industry and will help you to build a panoramic view of the industrial development.

    Nuclear Medicine and Radiopharmaceutic Market, By Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    Nuclear Medicine and Radiopharmaceutic Market, By Application:

    • Oncology

    • Cardiology

    • Others

    Some of the leading players are as follows:

    • China Isotope & Radiation

    • IBA Group

    • Mallinckrodt

    • SIEMENS

    • Advanced Accelerator Applications

    • Lantheus

    • Nordion

    • Jubilant Pharma

    • Dongcheng

    • GE Healthcare

    • Triad Isotopes

    • Bracco Imaging

    • Navidea

    • Eli Lilly

    • Company

    • Bayer

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine and Radiopharmaceutic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Diagnostic Radioisotopes

      • 1.3.2 Therapeutic Radioisotopes

    • 1.4 Market Segment by Application

      • 1.4.1 Oncology

      • 1.4.2 Cardiology

      • 1.4.3 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Nuclear Medicine and Radiopharmaceutic Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major Types

      • 3.4.1 Diagnostic Radioisotopes

      • 3.4.2 Therapeutic Radioisotopes

    4 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major End-Users

      • 4.4.1 Oncology

      • 4.4.2 Cardiology

      • 4.4.3 Others

    5 Market Analysis by Major Regions

    • 5.1 Global Nuclear Medicine and Radiopharmaceutic Production Analysis by Top Regions

    • 5.2 Global Nuclear Medicine and Radiopharmaceutic Consumption Analysis by Top Regions

    • 5.3 Global Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    6 Product Circulation of Nuclear Medicine and Radiopharmaceutic Market among Top Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 7.1 North America Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 7.1.1 United States Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 7.1.2 Canada Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 7.1.3 Mexico Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    8. Europe Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 8.1 Europe Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 8.2 Europe Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    • 8.3 Europe Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 8.3.1 Germany Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.2 UK Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.3 France Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.4 Italy Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.5 Spain Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.6 Belgium Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.7 Poland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.8 Russia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.9 Turkey Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.10 Netherlands Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.11 Portugal Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.12 Denmark Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.13 Finland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.14 Iceland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.15 Norway Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 8.3.16 Sweden Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 9.1 Asia Pacific Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 9.1.1 China Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 9.1.2 Japan Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 9.1.4 India Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 9.1.5 ASEAN Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 9.1.6 South Korea Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    10 LAMEA Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 10.1 LAMEA Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 10.1.2 Brazil Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 10.1.3 North Africa Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 10.1.4 South Africa Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 10.1.5 Argentina Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 China Isotope & Radiation

      • 11.1.1 China Isotope & Radiation China Isotope & Radiation Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 IBA Group

      • 11.2.1 IBA Group China Isotope & Radiation Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Mallinckrodt

      • 11.3.1 Mallinckrodt China Isotope & Radiation Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 SIEMENS

      • 11.4.1 SIEMENS China Isotope & Radiation Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Advanced Accelerator Applications

      • 11.5.1 Advanced Accelerator Applications China Isotope & Radiation Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Lantheus

      • 11.6.1 Lantheus China Isotope & Radiation Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Nordion

      • 11.7.1 Nordion China Isotope & Radiation Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Jubilant Pharma

      • 11.8.1 Jubilant Pharma China Isotope & Radiation Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Dongcheng

      • 11.9.1 Dongcheng China Isotope & Radiation Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 GE Healthcare

      • 11.10.1 GE Healthcare China Isotope & Radiation Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Triad Isotopes

      • 11.11.1 Triad Isotopes China Isotope & Radiation Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Bracco Imaging

      • 11.12.1 Bracco Imaging China Isotope & Radiation Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Navidea

      • 11.13.1 Navidea China Isotope & Radiation Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Eli Lilly

      • 11.14.1 Eli Lilly China Isotope & Radiation Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Company

      • 11.15.1 Company China Isotope & Radiation Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Bayer

      • 11.16.1 Bayer China Isotope & Radiation Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 95 Figures and 209 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Figure North America Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure United States Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure China Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine and Radiopharmaceutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine and Radiopharmaceutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Table Global Nuclear Medicine and Radiopharmaceutic Production by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceutic Production Share by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceutic Consumption by Major Regions

    • Table Global Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Regions

    • Table North America Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Europe Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table LAMEA Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table North America Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries in 2014

    • Figure North America Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries in 2018

    • Figure North America Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries in 2026

    • Figure United States Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure China Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure India Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company

    • Figure Sales and Growth Rate Analysis of Company

    • Figure Revenue and Market Share Analysis of Company

    • Table Product and Service Introduction of Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.